Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;19(1):31-8.
doi: 10.5588/ijtld.14.0373.

Latent tuberculous infection in the United States and Canada: who completes treatment and why?

Y Hirsch-Moverman  1 , R Shrestha-Kuwahara  2 , J Bethel  3 , H M Blumberg  4 , T K Venkatappa  5 , C R Horsburgh  6 , P W Colson  1 ; Tuberculosis Epidemiologic Studies Consortium (TBESC)
Collaborators, Affiliations

Latent tuberculous infection in the United States and Canada: who completes treatment and why?

Y Hirsch-Moverman et al. Int J Tuberc Lung Dis. 2015 Jan.

Abstract

Objectives: To assess latent tuberculous infection (LTBI) treatment completion rates in a large prospective US/Canada multisite cohort and identify associated risk factors.

Methods: This prospective cohort study assessed factors associated with LTBI treatment completion through interviews with persons who initiated treatment at 12 sites. Interviews were conducted at treatment initiation and completion/cessation. Participants received usual care according to each clinic's procedure. Multivariable models were constructed based on stepwise assessment of potential predictors and interactions.

Results: Of 1515 participants initiating LTBI treatment, 1323 had information available on treatment completion; 617 (46.6%) completed treatment. Baseline predictors of completion included male sex, foreign birth, not thinking it would be a problem to take anti-tuberculosis medication, and having health insurance. Participants in stable housing who received monthly appointment reminders were more likely to complete treatment than those without stable housing or without monthly reminders. End-of-treatment predictors of non-completion included severe symptoms and the inconvenience of clinic/pharmacy schedules, barriers to care and changes of residence. Common reasons for treatment non-completion were patient concerns about tolerability/toxicity, appointment conflicts, low prioritization of TB, and forgetfulness.

Conclusions: Less than half of treatment initiators completed treatment in our multisite study. Addressing tangible issues such as not having health insurance, toxicity concerns, and clinic accessibility could help to improve treatment completion rates.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure
Figure
Participant flow. LTBI = latent tuberculous infection; INH = isoniazid.
See this image and copyright information in PMC

References

    1. Bennett DE, Courval JM, Onorato I, et al. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999–2000. Am J Respir Critical Care Med. 2008;177:348–355. - PubMed
    1. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am Respir Critical Care Med. 2000;161(4 Pt 2):S221–S247. - PubMed
    1. Geiter L, editor. Ending neglect: the elimination of tuberculosis in the United States. Washington, DC, USA: National Academy Press; 2000. - PubMed
    1. Sterling TR, Bethel J, Goldberg S, Weinfurter P, Yun L, Horsburgh CR, Tuberculosis Epidemiologic Studies Consortium The scope and impact of treatment of latent tuberculosis infection in the United States and Canada. Am J Respir Critical Care Med. 2006;173:927–931. - PubMed
    1. Centers for Disease Control and Prevention. Recommendations for targeted tuberculin testing and treatment of LTBI. MMWR Morb Mortal Wkly Rep. 2000;49:1–54.

Publication types

LinkOut - more resources